Mô tả
In vivo diabetic wound healing data showing the progression of wound closure in liraglutide-treated versus untreated diabetic animals. Wound area measurements over time demonstrate accelerated healing in the treatment group.
Figure 3
PhotographSource Paper
Liraglutide Promotes Diabetic Wound Healing via Myo1c/Dock5.Advanced science (Weinheim, Baden-Wurttemberg, Germany) (2024)
PMID: 39159301
Cite This Figure
![Figure 3: In vivo diabetic wound healing data showing the progression of wound closure in liraglutide-treated versus untreated diabetic animals. Wound area measurements over time demonstrate accelerated healing in the treatment group.]() > Source: Qian Zhang et al. "Liraglutide Promotes Diabetic Wound Healing via Myo1c/Dock5.." *Advanced science (Weinheim, Baden-Wurttemberg, Germany)*, 2024. PMID: [39159301](https://pubmed.ncbi.nlm.nih.gov/39159301/)
<figure> <img src="" alt="In vivo diabetic wound healing data showing the progression of wound closure in liraglutide-treated versus untreated diabetic animals. Wound area measurements over time demonstrate accelerated healing in the treatment group." /> <figcaption>Figure 3. In vivo diabetic wound healing data showing the progression of wound closure in liraglutide-treated versus untreated diabetic animals. Wound area measurements over time demonstrate accelerated healing in the treatment group.<br> Source: Qian Zhang et al. "Liraglutide Promotes Diabetic Wound Healing via Myo1c/Dock5.." <em>Advanced science (Weinheim, Baden-Wurttemberg, Germany)</em>, 2024. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/39159301/">39159301</a></figcaption> </figure>